LGBT Cancer Project

Therapeutic Areas: Oncology | Hematology | Musculoskeletal

Leukemia Clinical Trials

A listing of Leukemia medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

UPDATED

Phoenix Arizona 85016

A clinical research study of Carfilzomib, Cyclophosphamide and Etoposide for the treatment of Relapsed Solid Tumors, Refractory Solid Tumors or Leukemias

California

UPDATED

Duarte California 91010

A clinical trial to evaluate treatments using Guadecitabine and Treatment Choice for patients with Myelodysplastic Syndromes or Leukemia, Myelomonocytic, Chronic

UPDATED

Los Angeles California 90033

A clinical research study of guadecitabine and Treatment Choice (TC) for the treatment of Acute Myeloid Leukemia

UPDATED

Rancho Mirage California 92270

A clinical trial to evaluate treatments using Guadecitabine and Treatment Choice for patients with Myelodysplastic Syndromes or Leukemia, Myelomonocytic, Chronic

UPDATED

San Francisco California 94143

A clinical research study of DS-3032b for the treatment of Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia or Myelodysplastic Syndrome

Colorado

UPDATED

Aurora Colorado 80045

A clinical trial seeking patients for a Cancer treatment research study

Florida

UPDATED

Fleming Island Florida 32003

A clinical trial to evaluate treatments using Guadecitabine and Treatment Choice for patients with Myelodysplastic Syndromes or Leukemia, Myelomonocytic, Chronic

UPDATED

Jacksonville Florida 32224

Patients are needed to participate in a clinical research study of Decitabine and BI 836858 to evaluate Leukemia, Myeloid, Acute

UPDATED

Miami Beach Florida 33140

A clinical trial to evaluate treatments using Guadecitabine and Treatment Choice for patients with Myelodysplastic Syndromes or Leukemia, Myelomonocytic, Chronic

Illinois

UPDATED

Chicago Illinois 60637

A clinical research study of guadecitabine and Treatment Choice (TC) for the treatment of Acute Myeloid Leukemia

UPDATED

Chicago Illinois 60612

A clinical trial to evaluate treatments using Guadecitabine and Treatment Choice for patients with Myelodysplastic Syndromes or Leukemia, Myelomonocytic, Chronic

UPDATED

Chicago Illinois 60611

Patients are needed to participate in a clinical research study of Decitabine and BI 836858 to evaluate Leukemia, Myeloid, Acute

UPDATED

Evanston Illinois 60201

A clinical trial to evaluate treatments using Guadecitabine and Treatment Choice for patients with Myelodysplastic Syndromes or Leukemia, Myelomonocytic, Chronic

UPDATED

Niles Illinois 60714

A Phase 3 clinical study for patients with Newly Diagnosed Acute Myeloid Leukemia (AML), Untreated AML, AML Arising From Myelodysplastic Syndrome (MDS) or Leukemia, Myeloid, Acute

Indiana

UPDATED

Indianapolis Indiana 46237

A clinical research study of guadecitabine and Treatment Choice (TC) for the treatment of Acute Myeloid Leukemia

UPDATED

Indianapolis Indiana 46237

A Phase 3 clinical study for patients with Newly Diagnosed Acute Myeloid Leukemia (AML), Untreated AML, AML Arising From Myelodysplastic Syndrome (MDS) or Leukemia, Myeloid, Acute

Kentucky

UPDATED

Louisville Kentucky 40207

A Phase 3 clinical study for patients with Newly Diagnosed Acute Myeloid Leukemia (AML), Untreated AML, AML Arising From Myelodysplastic Syndrome (MDS) or Leukemia, Myeloid, Acute

Maryland

UPDATED

Baltimore Maryland 21201

A clinical trial to evaluate treatments using Guadecitabine and Treatment Choice for patients with Myelodysplastic Syndromes or Leukemia, Myelomonocytic, Chronic

Michigan

UPDATED

Ann Arbor Michigan 48109

A clinical trial to evaluate treatments using Guadecitabine and Treatment Choice for patients with Myelodysplastic Syndromes or Leukemia, Myelomonocytic, Chronic

New Jersey

UPDATED

Hackensack New Jersey 07601-1915

A clinical research study of guadecitabine and Treatment Choice (TC) for the treatment of Acute Myeloid Leukemia

UPDATED

Hackensack New Jersey 07601

A clinical trial to evaluate treatments using Guadecitabine and Treatment Choice for patients with Myelodysplastic Syndromes or Leukemia, Myelomonocytic, Chronic

New Mexico

UPDATED

Albuquerque New Mexico 87106

A clinical research study of guadecitabine and Treatment Choice (TC) for the treatment of Acute Myeloid Leukemia

New York

UPDATED

Buffalo New York 14263

A clinical research study of guadecitabine and Treatment Choice (TC) for the treatment of Acute Myeloid Leukemia

UPDATED

Buffalo New York 14263

A clinical trial to evaluate treatments using Guadecitabine and Treatment Choice for patients with Myelodysplastic Syndromes or Leukemia, Myelomonocytic, Chronic

UPDATED

New York New York 10021

A clinical research study of guadecitabine and Treatment Choice (TC) for the treatment of Acute Myeloid Leukemia

UPDATED

New York New York 10065

A clinical trial seeking patients for a Cancer treatment research study

UPDATED

New York New York 10065

A clinical trial to evaluate treatments using Guadecitabine and Treatment Choice for patients with Myelodysplastic Syndromes or Leukemia, Myelomonocytic, Chronic

UPDATED

Stony Brook New York 11794

A clinical research study of guadecitabine and Treatment Choice (TC) for the treatment of Acute Myeloid Leukemia

UPDATED

Stony Brook New York 11794

A clinical trial to evaluate treatments using Guadecitabine and Treatment Choice for patients with Myelodysplastic Syndromes or Leukemia, Myelomonocytic, Chronic

UPDATED

Stony Brook New York 11794

A Phase 3 clinical study for patients with Newly Diagnosed Acute Myeloid Leukemia (AML), Untreated AML, AML Arising From Myelodysplastic Syndrome (MDS) or Leukemia, Myeloid, Acute

North Carolina

UPDATED

Durham North Carolina 27710

A clinical research study of guadecitabine and Treatment Choice (TC) for the treatment of Acute Myeloid Leukemia

UPDATED

Durham North Carolina 27705

A clinical trial to evaluate treatments using Guadecitabine and Treatment Choice for patients with Myelodysplastic Syndromes or Leukemia, Myelomonocytic, Chronic

UPDATED

Durham North Carolina 27705

A Phase 3 clinical study for patients with Newly Diagnosed Acute Myeloid Leukemia (AML), Untreated AML, AML Arising From Myelodysplastic Syndrome (MDS) or Leukemia, Myeloid, Acute

Ohio

UPDATED

Canton Ohio 44718

A Phase 3 clinical study for patients with Newly Diagnosed Acute Myeloid Leukemia (AML), Untreated AML, AML Arising From Myelodysplastic Syndrome (MDS) or Leukemia, Myeloid, Acute

UPDATED

Cincinnati Ohio 45242

A Phase 3 clinical study for patients with Newly Diagnosed Acute Myeloid Leukemia (AML), Untreated AML, AML Arising From Myelodysplastic Syndrome (MDS) or Leukemia, Myeloid, Acute

UPDATED

Columbus Ohio 43210

Patients are needed to participate in a clinical research study of Decitabine and BI 836858 to evaluate Leukemia, Myeloid, Acute

Pennsylvania

UPDATED

Hershey Pennsylvania 17033

A clinical trial to evaluate treatments using Guadecitabine and Treatment Choice for patients with Myelodysplastic Syndromes or Leukemia, Myelomonocytic, Chronic

UPDATED

Philadelphia Pennsylvania 19111-2433

A clinical research study of guadecitabine and Treatment Choice (TC) for the treatment of Acute Myeloid Leukemia

UPDATED

Philadelphia Pennsylvania 19111

A clinical trial to evaluate treatments using Guadecitabine and Treatment Choice for patients with Myelodysplastic Syndromes or Leukemia, Myelomonocytic, Chronic

South Carolina

UPDATED

Charleston South Carolina 29425

A clinical trial to evaluate treatments using Guadecitabine and Treatment Choice for patients with Myelodysplastic Syndromes or Leukemia, Myelomonocytic, Chronic

UPDATED

Greenville South Carolina 29607

A clinical trial to evaluate treatments using Guadecitabine and Treatment Choice for patients with Myelodysplastic Syndromes or Leukemia, Myelomonocytic, Chronic

UPDATED

Greenville South Carolina 29615

A Phase 3 clinical study for patients with Newly Diagnosed Acute Myeloid Leukemia (AML), Untreated AML, AML Arising From Myelodysplastic Syndrome (MDS) or Leukemia, Myeloid, Acute

Tennessee

UPDATED

Nashville Tennessee 37232

A clinical research study of guadecitabine and Treatment Choice (TC) for the treatment of Acute Myeloid Leukemia

Texas

UPDATED

Houston Texas 77031

A clinical research study of DS-3032b for the treatment of Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia or Myelodysplastic Syndrome

UPDATED

Houston Texas 77030

A clinical research study of guadecitabine and Treatment Choice (TC) for the treatment of Acute Myeloid Leukemia

UPDATED

Houston Texas 77030

A clinical research study of SGI-110, Idarubicin and Cladribine for the treatment of Leukemia

UPDATED

Houston Texas 77030

A clinical trial seeking patients for a Cancer treatment research study

UPDATED

Houston Texas 77030

A clinical trial to evaluate treatments using Guadecitabine and Treatment Choice for patients with Myelodysplastic Syndromes or Leukemia, Myelomonocytic, Chronic

UPDATED

Houston Texas 77030

A clinical trial to evaluate treatments using Omacetaxine for patients with Leukemia

UPDATED

Houston Texas 77030

Patients are needed to participate in a clinical research study evaluating 5-azacytidine, Lirilumab and Phone Call for the treatment of Leukemia, Refractory/Relapsed Acute Myeloid Leukemia